Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
12/13/2001 | US20010051221 Functionalization of substrate surfaces with silane mixtures |
12/13/2001 | US20010051113 Determinating nucleotide polymorphism |
12/13/2001 | US20010051111 Device for extracting and taking samples from an aqueous solution in a substrate |
12/13/2001 | US20010050555 Paramagnetic particle detection |
12/13/2001 | US20010050339 On-the-go sugar sensor for determining sugar content during harvesting |
12/13/2001 | US20010050228 Thin plastic substrate |
12/13/2001 | US20010049972 Dual windup extensional rheometer |
12/13/2001 | US20010049969 Apparatus and method for testing material performance |
12/13/2001 | US20010049968 Apparatus for and method of measuring thermal stress of concrete structure |
12/13/2001 | DE10062626A1 Cartilage replacement, useful particularly for repairing joint defects, comprises differentiated and proliferating chondrocytes in collagen-based biomatrix |
12/13/2001 | DE10062623A1 Cartilage replacement, useful particularly for repairing joint defects, comprises differentiated and proliferating chondrocytes in collagen-based biomatrix |
12/13/2001 | DE10028058A1 Verfahren und Einrichtung zum Beizen eines gewalzten Metallstranges, insbesondere eines Stahlbandes Method and device for pickling a rolled metal strip, particularly a steel strip |
12/13/2001 | DE10027397A1 Oberfläche zur Immobilisierung von Liganden Surface for immobilization of ligands |
12/13/2001 | DE10027308A1 Analyzing endogenous or exogenous cell activation for the diagnosis of e.g systemic inflammation comprises measuring assembly of CD14-containing receptor cluster |
12/13/2001 | DE10027170A1 Humanes PEM als Target für die Fertilitätskontrolle Human PEM as a target for fertility control |
12/13/2001 | DE10026833A1 Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens A method for identifying compounds for modulating the activity of a tumor suppressor |
12/13/2001 | DE10026789A1 Knorpelersatz und Verfahren zu dessen Herstellung Cartilage replacement and process for its preparation |
12/13/2001 | DE10016077A1 Automated testing of activity of cell-modifying agents useful for selecting cytostatic agents for particular treatments |
12/13/2001 | CA2810249A1 Identification and use of human bone marrow-derived endothelial progenitor cell to improve myocardial function after ischemic injury |
12/13/2001 | CA2594659A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591930A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591929A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591814A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591656A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591590A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591583A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2585822A1 Breast, rectal, colon and lung tumour marker pro19628 polypeptide and encoding nucleic acid |
12/13/2001 | CA2416868A1 Identification and use of molecular markers indicating cellular reprogramming |
12/13/2001 | CA2414061A1 Metalloprotease peptide substrates and methods |
12/13/2001 | CA2412567A1 Charge-switch nucleotides |
12/13/2001 | CA2412413A1 Asynchronous primed pcr |
12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
12/13/2001 | CA2411849A1 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
12/13/2001 | CA2411719A1 Novel g-protein coupled receptor |
12/13/2001 | CA2411609A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
12/13/2001 | CA2411601A1 Cancer gene determination and therapeutic screening using signature gene sets |
12/13/2001 | CA2411573A1 Method and apparatus for washing and drying pins in microarray spotting instruments |
12/13/2001 | CA2411473A1 Compositions, kits, and methods for identification and modulation of type i diabetes |
12/13/2001 | CA2411465A1 Visual-servoing optical microscopy |
12/13/2001 | CA2411139A1 Inhibitors of c-reactive protein induced inflammation |
12/13/2001 | CA2411126A1 Labeling of proteomic samples during proteolysis for quantitation and sample multiplexing |
12/13/2001 | CA2410894A1 Flow cytometry-based hematology system |
12/13/2001 | CA2410879A1 Novel compositions and methods for array-based nucleic acid hybridization |
12/13/2001 | CA2410513A1 3d array of integrated cells for the sampling and detection of air bound chemical and biological species |
12/13/2001 | CA2410510A1 Artificial antigen presenting cells and methods of use thereof |
12/13/2001 | CA2410458A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury |
12/13/2001 | CA2410281A1 Methods and devices for multiplexing amplification reactions |
12/13/2001 | CA2410162A1 Breast, rectal, colon and lung tumor marker pro 4332 polypeptide and encoding nucleic acid |
12/13/2001 | CA2409989A1 Diagnostic methods for pompe disease and other glycogen storage diseases |
12/13/2001 | CA2409944A1 Stable isotope labeling of paclitaxel |
12/13/2001 | CA2409392A1 Intracellular signaling proteins |
12/13/2001 | CA2409342A1 Extracellular messengers |
12/13/2001 | CA2408748A1 Nuclear hormone receptor |
12/13/2001 | CA2407934A1 Assay for detection of transferase enzyme activity in drug screening |
12/13/2001 | CA2407718A1 Assay for detection of translocase enzyme activity in drug screening |
12/13/2001 | CA2381249A1 Methods and compositions for modulating oxidized ldl transport |
12/12/2001 | EP1162464A1 Method and device for increasing efficiency of bioanalysis |
12/12/2001 | EP1162463A2 Collection device for blood |
12/12/2001 | EP1162462A2 Assay method for hemoglobin using lipoproteins |
12/12/2001 | EP1162461A2 Automated method for detecting, quantifying and monitoring exogenous hemoglobin in whole blood, plasma and serum |
12/12/2001 | EP1162459A1 Rough charged solid phase for attachment of biomolecules |
12/12/2001 | EP1162458A1 Methods and compositions for modulating oxidized LDL transport |
12/12/2001 | EP1162457A2 Multiple coagulation test system and method of using a multiple coagulation test system |
12/12/2001 | EP1162455A1 Apparatus and method for performing microfluidic manipultions for chemical analysis and synthesis |
12/12/2001 | EP1162453A1 Electrochemical sensor with improved reproducibility |
12/12/2001 | EP1162451A1 Dry measuring test device |
12/12/2001 | EP1162287A2 Process and apparatus for pickling a rolled metal strand, particularly for steel strip |
12/12/2001 | EP1162277A2 Probes and methods for detection of nucleic acids |
12/12/2001 | EP1162274A1 Method for identifying compounds modifying methyltransferase-dependent chromosome stability |
12/12/2001 | EP1162270A2 Phagemids coexpressing a surface receptor and a surface heterologous protein |
12/12/2001 | EP1162269A1 Novel polypeptide |
12/12/2001 | EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy |
12/12/2001 | EP1162264A2 Chimeric hormone receptor |
12/12/2001 | EP1162262A1 Fibers having nucleic acid immobilized thereon, alignment of fibers having nucleic acid immobilized thereon and slice thereof |
12/12/2001 | EP1161997A2 Cuvette stand and stand with cuvettes |
12/12/2001 | EP1161996A2 Cuvette stand and stand with cuvettes |
12/12/2001 | EP1161943A2 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
12/12/2001 | EP1161689A1 Method and device for detection of apo a, apo b and the ratio thereof in saliva |
12/12/2001 | EP1161688A2 Colorimetric detection method |
12/12/2001 | EP1161687A1 Grb14 and the insulin receptor and screening of novel medicines |
12/12/2001 | EP1161686A2 Diagnostics and therapeutics for drusen associated ocular disorders |
12/12/2001 | EP1161685A1 Method for reducing fluorescence quenching in bioassays |
12/12/2001 | EP1161684A1 Centrifugally-enhanced method of determining ligand/target affinity |
12/12/2001 | EP1161683A1 Determination of the chemosensitivity via phosphatidyl serine |
12/12/2001 | EP1161682A1 Collection well for body fluid tester |
12/12/2001 | EP1161681A2 Use of lna in mass spectrometry |
12/12/2001 | EP1161680A1 Method of diagnosing and monitoring malignant breast carcinomas |
12/12/2001 | EP1161679A1 Meat imaging system for palatability and yield prediction |
12/12/2001 | EP1161678A1 Hybrid film type sensor |
12/12/2001 | EP1161674A1 Brewster angle light scattering cell |
12/12/2001 | EP1161672A1 A device for detecting the presence of a chemical contaminant |
12/12/2001 | EP1161670A1 Measurement systems and methods for determining component particle concentrations in a liquid |
12/12/2001 | EP1161666A1 Method and apparatus for sealing test materials |
12/12/2001 | EP1161596A1 Device for determining the characteristics of a running material web |
12/12/2001 | EP1161563A2 Probe/mobility modifier complexes for multiplex nucleic acid detection |
12/12/2001 | EP1161560A1 Electropolymerizable film, and method of making and use thereof |
12/12/2001 | EP1161559A1 Rapid diagnostic method for distinguishing allergies and infections |
12/12/2001 | EP1161558A1 Intact cell assay for protein tyrosine phosphatases |
12/12/2001 | EP1161557A2 Determination of the chemosensitivity via the caspase activity |
12/12/2001 | EP1161555A1 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system |